Carotid body size on CTA: correlation with comorbidities

Area of Science:

• Vascular imaging
• Cardiology
• Endocrinology

Background:

• Carotid bodies play a role in sympathetic nervous system regulation.
• Enlargement of carotid bodies may be associated with sympathetically mediated diseases.

Purpose of the Study:

• To determine if computed tomographic angiography (CTA) can detect carotid body enlargement in patients with sympathetically mediated diseases.
• To investigate the relationship between carotid body size and conditions such as diabetes mellitus, hypertension, and congestive heart failure.

Main Methods:

• Retrospective review of cervical CTA scans from 288 patients.
• Measurement of carotid body diameters using PACS.
• Statistical comparison of mean carotid body size between control and patient groups.

Main Results:

• Mean carotid body diameter in controls was 2.3 mm.
• Patients with diabetes mellitus, hypertension, and congestive heart failure showed a statistically significant 20-25% increase in mean carotid body diameter (2.8 mm, 2.7 mm, and 2.7 mm, respectively).
• The observed enlargement was small and unlikely to be mistaken for a paraganglioma.

Conclusions:

• Patients with diabetes mellitus, hypertension, and congestive heart failure exhibit a modest enlargement of carotid bodies.
• These findings support a functional connection between the carotid body and sympathetically mediated disease states.
• CTA is a valuable tool for assessing carotid body size in the context of these conditions.